Viewing Study NCT01501266


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-06-04 @ 6:53 PM
Study NCT ID: NCT01501266
Status: COMPLETED
Last Update Posted: 2016-05-10
First Post: 2011-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Faslodex Specific Clinical Experience Investigation
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None postmenopausal breast cancer View
None Faslodex View
None cohort View